jRCT2080222627已完成3 期
A Phase 3 Study of CS-8958 (Prophylaxis for children) - A randomized, double-blind, placebo-controlled study to evaluate the efficacy for the prevention of influenza virus infection in children under 10 years-
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multicenter, randomized, double-blind, 2-parallel-group, placebo-controlled
- 主要目的
- Prevention Purpose
入排标准
- 年龄范围
- No limit 至 9age old under（—）
- 性别
- All
入选标准
- •Household contact of a patient with influenza virus infection
- •Body temperature (axillary) at informed consent =< 36.9 degrees C
- •No influenza symptoms
- •Be capable of inhaling drug judged by investigator
排除标准
- •Persons who are unable to cohabit with an index patient
- •Persons who cannot start study treatment within 48 hours after the initial onset of any influenza symptom in the index patient
- •Persons receiving corticosteroids or immunosuppressants
- •Persons who have a history of hypersensitivity to a neuraminidase inhibitor
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Phase 3 Study of CS-8958 (Prophylaxis of Single Administration)jRCT2080222628DAIICHI SANKYO CO., LTD.750
已完成
3 期
A Phase 3 Study of CS-8958 (Prophylaxis for children)JPRN-jRCT2080222627DAIICHI SANKYO CO., LTD.343
已完成
3 期
A Phase 3 Study of nebulized CS-8958 (Pediatric Patients < 10 years of age)jRCT2080223343DAIICHI SANKYO Co.,Ltd.150
已完成
3 期
A Phase 3 Study of CS-8958 (Prophylaxis of Single Administration)JPRN-jRCT2080222628DAIICHI SANKYO CO., LTD.803
已完成
3 期
A Phase 3 Study of nebulized CS-8958 (Pediatric Patients < 10 years of age)Influenza A or B virus infectionJPRN-jRCT2080223343DAIICHI SANKYO Co.,Ltd.173